Deleting one gene left malaria parasites unable to convert under fever, starvation or drug stress

gdv1 and ap2-g were already known to initiate gametocyte formation, and nutrient limitation was already known to push parasites in that direction, but the trigger linking the two was unidentified ^[4]. Applying three unrelated stresses one at a time, each with its own multi-omic readout, is what made the linking step testable ^[5]. If starvation, drug pressure and heat each had a private route into sexual conversion, the gene and chromatin changes should have looked different in each case ^[6]. "All three stimuli activated the same regulatory pathway. They all triggered similar changes in the gdv1 and ap2-g genes," said Elisabet Tinto, the ISGlobal researcher and first author of the study ^[7].

Convergence on its own would leave the pathway a correlate of stress, so the deletion tests whether it is required. "When we deleted the ap2-hs gene, the parasites completely lost their ability to develop into gametocytes, even under stressful conditions such as fever, DHA treatment or nutrient limitation. Moreover, the few gametocytes that began to develop failed to become viable," Tinto said ^[11].

AP2-HS does more than one job. On detecting stress it activates GDV1, and it also switches on other stress-survival mechanisms in the parasite ^[10]. A compound aimed at AP2-HS would be acting on both, and anyone calling it a transmission-blocking drug would have to separate the two effects first.

There is a brake in the circuit too. GDV1 starts conversion and at the same time induces gdv1-as, an RNA that represses gdv1, which keeps the response fast and short; the authors describe sustained GDV1 expression as something that could otherwise prove lethal to the parasite ^[9].

Of the three stimuli, one is a drug clinicians administer: the antimalarial DHA ^[5]. The experiments measured gene activation, protein abundance and chromatin organization in parasites, with the fever episode simulated ^[6], and the account of the study does not report mosquito feeding or patient results. So the supported statement is narrow: drug pressure engages the conversion machinery in blood-stage parasites. Whether a course of DHA measurably raises onward transmission in a treated population would take a separate experiment with a different denominator.

"This work helps answer a question that had remained unresolved for years: how the parasite adapts its life cycle to a changing environment and produces the transmissible forms that are essential for its survival at the population level," said Alfred Cortes, the ICREA researcher at ISGlobal who coordinated the study ^[12]. Population level is also where a drug against this pathway would have to prove itself. Gametocytes are the forms that pass to other people through mosquitoes ^[2], so blocking their production changes who gets infected next.